Trials / Conditions / Secondary Hyperparathyroidism, Chronic Kidney Disease
Secondary Hyperparathyroidism, Chronic Kidney Disease
3 registered clinical trials studyying Secondary Hyperparathyroidism, Chronic Kidney Disease — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism NCT07122401 | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | Phase 3 |
| Terminated | Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary NCT02859896 | Sanofi | Phase 3 |
| Completed | Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With NCT02341417 | Amgen | Phase 3 |